It would appear that one of the most interesting medical marijuana byproducts is soon going to become available for patients who are suffering from chronic, cancer, MS spasticity and neuropathic pain. Two of the most hard working marijuana innovators CanChew Biotecnologies and Medical Marijuana Inc., have joined forces and are about to release a new medical marijuana derivative – a CBD enriched chewing gum.
Simply called ‘CanChew‘, this particular chewing gum contains no THC and is therefore ‘high-free”, just like Avidekel, that Israel strain of weed also grown in a lab, void of almost any TCH but rich with CBD. It would appear that there is no end to medical marijuana innovation as this product may indeed prove to be revolutionary. The chewing gum is essentially based on CBD oil and quite a large number of medical marijuana studies have proven to show that CBD will definitely provide patients with the necessary relief in cases mentioned above.
The Cannabis Industry
But lets put humanity aside for a second. After all, the medical marijuana business is no small industry. In fact, it is estimated that the market for such products is worth about 5 billion dollars. No wonder investors started to notice a fertile ground for medical marijuana products. Even though some people don’t necessarily believe that medical marijuana is a cure in disguise, they still see a golden opportunity in investing into medical marijuana research studies and future experiments.
Free Testing Phase
In about a week or so (October 15th), patients eager to test the medical marijuana chewing gum will be able to sign up online to receive a free one-month supply of CBD enriched CanChew. Obviously, not everyone will be able to get it, only those who prove to be eligible for this free testing phase. If all goes well, you can expect CanChew filling up the shelves of local dispensaries by the end of 2013. Considering the fact that human trials haven’t even begun by the time this article was written, we’d say 2013 could prove out to be one of the best years so far in the medical marijuana industry.
The employees of CanChew Biotechnologies are extremely excited to get this product out to the public, as they believe it just may change patients’ lives. They wanted to get the product out this year but instead they decided to focus on receiving the initial patients feedback in the testing phase, which is a good thing. That way, we wont be getting a semi-product that had potential but an original product that actually delivers.
CanChew Biotechnologies are a friendly company with a clear mission of delivering only the high-end cannabis pharmaceuticals. They also emphasize the rather quick absorption of the CDB compound when chewed and believe in full success of this product when it hits the market next year. We wish them the best as well!